A "broken" investment model means a new antibiotic may not reach the market for another decade, according to the head of a $1 billion Big Pharma-backed fund focused on the growing threat of drug-re | Despite the growing threat posed by drug-resistant bacteria, new antibiotics may not reach the...
I remember running into a series of 'phenyl isobutanamines' that were toted as anorexics. `In essence, it's just the beta carbon having a methyl side-chain. I guess it was for patent purposes....
OK, UK law would outlaw product, but unlike BMK, the precursor WOULD be legal.... so costing is the watchword.